相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy
Ryoji Kamei et al.
ONCOLOGY LETTERS (2018)
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient
David A. Sallman et al.
HAEMATOLOGICA (2018)
Innate-like Cytotoxic Function of Bystander-Activated CD8+ T Cells Is Associated with Liver Injury in Acute Hepatitis A
Jihye Kim et al.
IMMUNITY (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner
Stefan Balint et al.
SCIENCE SIGNALING (2018)
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient
David A. Sallman et al.
HAEMATOLOGICA (2018)
A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner
Stefan Balint et al.
SCIENCE SIGNALING (2018)
ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell-mediated innate immune response in human hepatocytes
Hiromichi Dansako et al.
FEBS OPEN BIO (2018)
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
Ana Stojanovic et al.
FRONTIERS IN IMMUNOLOGY (2018)
NKG2D and Its Ligands: One for All, All for One
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2018)
Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice
Dina Al Dulaimi et al.
FRONTIERS IN IMMUNOLOGY (2018)
More than Decoration: Roles for Natural Killer Group 2 Member D Ligand expression by immune Cells
Andrew P. Trembath et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
Nicholas J. W. Easom et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1
Shuhei Hosomi et al.
FRONTIERS IN IMMUNOLOGY (2018)
NKG2D-ligands: Putting everything under the same umbrella can be misleading
C. Campos-Silva et al.
HLA (2018)
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial
Matthieu Allez et al.
GUT (2017)
T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System
Wei-Chen Huang et al.
JOURNAL OF IMMUNOLOGY (2017)
NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration
Kasper Vadstrup et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2017)
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Guoying Zhou et al.
GASTROENTEROLOGY (2017)
NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice
Li Qian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation
Shuhei Hosomi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release
Neekun Sharma et al.
JOURNAL OF IMMUNOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
Martina Molgora et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update
Masatoshi Kudo
ONCOLOGY (2017)
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Sam Sheppard et al.
NATURE COMMUNICATIONS (2017)
Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma
Yuanji Xu et al.
ONCOTARGET (2017)
ULBPs: regulators of human lymphocyte stress recognition
Jianmin Zuo et al.
ONCOTARGET (2017)
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
Thornton W. Thompson et al.
ELIFE (2017)
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions
Amanda R. Campbell et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases
Jiemiao Hu et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation
Maulik Vyas et al.
ONCOIMMUNOLOGY (2017)
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients
Cristina Maccalli et al.
ONCOIMMUNOLOGY (2017)
Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
Jingyu Zhang et al.
SCIENCE ADVANCES (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue
Hormas Ghadially et al.
BRITISH JOURNAL OF CANCER (2017)
Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma
Muhammad Ramzan et al.
LIVER INTERNATIONAL (2016)
Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development
Jessica Endig et al.
CANCER CELL (2016)
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice
Marie-Louise Sentman et al.
JOURNAL OF IMMUNOLOGY (2016)
NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo
Saravanan Raju et al.
JOURNAL OF IMMUNOLOGY (2016)
Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus-dominant lymphocytic gastritis
Ana Montalban-Arques et al.
JOURNAL OF PATHOLOGY (2016)
Immunosurveillance of the Liver by Intravascular Effector CD8+ T Cells
Luca G. Guidotti et al.
CELL (2015)
The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation
Antje Isernhagen et al.
EMBO MOLECULAR MEDICINE (2015)
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
Li Wang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)
Genetics, genomics, and evolutionary biology of NKG2D ligands
Raphael Carapito et al.
IMMUNOLOGICAL REVIEWS (2015)
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
Heather VanSeggelen et al.
MOLECULAR THERAPY (2015)
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
Shlomi Finkin et al.
NATURE IMMUNOLOGY (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells
Linda Quatrini et al.
SCIENCE SIGNALING (2015)
The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies
Tobias Ruck et al.
ONCOTARGET (2015)
Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells
Linda Quatrini et al.
SCIENCE SIGNALING (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
Hanbyoul Cho et al.
BMC CANCER (2014)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
Regulation of CD4(+)NKG2D(+) Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15R alpha and NKG2D Triggering
Ana I. Romero et al.
CANCER RESEARCH (2014)
MICA polymorphism: biology and importance in cancer
Dan Chen et al.
CARCINOGENESIS (2014)
Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation
Nazanin Farhadi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma
Liang Fang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Genetics of hepatocellular carcinoma: The next generation
Jean-Charles Nault et al.
JOURNAL OF HEPATOLOGY (2014)
Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients
Courtney A. Crane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells
Sarah S. Donatelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
NK cell autoreactivity and autoimmune diseases
Alessandro Poggi et al.
FRONTIERS IN IMMUNOLOGY (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Chemokines in tissue fibrosis
Hacer Sahin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
A selective role of NKG2D in inflammatory and autoimmune diseases
Nadia Guerra et al.
CLINICAL IMMUNOLOGY (2013)
Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice
Mei Huang et al.
HEPATOLOGY (2013)
Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis
Gang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Decoding cell death signals in liver inflammation
Catherine Brenner et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants
H. V. Tong et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Effector CD8 T cell trafficking within the liver
Luca G. Guidotti et al.
MOLECULAR IMMUNOLOGY (2013)
Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk
Paulisally Hau Yi Lo et al.
PLOS ONE (2013)
Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy
Yu Chen et al.
PLOS ONE (2013)
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
G. Chitadze et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
Esther M. de Kruijf et al.
BMC CANCER (2012)
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
Pengyuan Yang et al.
CANCER CELL (2012)
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
Carlo Schneider et al.
GUT (2012)
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection
Stefania Varchetta et al.
HEPATOLOGY (2012)
RAE-1ε Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition
Mary A. Markiewicz et al.
IMMUNITY (2012)
Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner
Naoko Yamada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice
Marie Anson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
Heiyoun Jung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence
Hiroteru Kamimura et al.
JOURNAL OF HEPATOLOGY (2012)
NKG2D Mediates NK Cell Hyperresponsiveness and Influenza-Induced Pathologies in a Mouse Model of Chronic Obstructive Pulmonary Disease
Brian W. Wortham et al.
JOURNAL OF IMMUNOLOGY (2012)
TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
Cheng Sun et al.
PLOS PATHOGENS (2012)
Immunotherapy of hepatocellular carcinoma Unique challenges and clinical opportunities
Angela D. Pardee et al.
ONCOIMMUNOLOGY (2012)
Blockade of NKG2D Ameliorates Disease in Mice With Collagen-Induced Arthritis A Potential Pathogenic Role in Chronic Inflammatory Arthritis
Anna K. Andersson et al.
ARTHRITIS AND RHEUMATISM (2011)
Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2
Hyunho Yoon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Immune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis
Mingcan Xia et al.
CIRCULATION (2011)
Activation of the Receptor NKG2D Leads to Production of Th17 Cytokines in CD4+ T Cells of Patients With Crohn's Disease
Benjamin Pariente et al.
GASTROENTEROLOGY (2011)
A dual role for the immune response in a mouse model of inflammation-associated lung cancer
Michael Dougan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells
Zhangguo Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Cutting Edge: A Dual Role for Type I IFNs during Polyinosinic-Polycytidylic Acid-Induced NK Cell Activation
Helene Beuneu et al.
JOURNAL OF IMMUNOLOGY (2011)
Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection
Ya-Ting Chang et al.
PLOS ONE (2011)
The Intraepithelial T Cell Response to NKG2D-Ligands Links Lymphoid Stress Surveillance to Atopy
Jessica Strid et al.
SCIENCE (2011)
Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
Omodele Ashiru et al.
CANCER RESEARCH (2010)
Major Histocompatibility Complex Class I-Related Chains A and B (MIC A/B): A Novel Role in Nonalcoholic Steatohepatitis
Alisan Kahraman et al.
HEPATOLOGY (2010)
Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8+ T Cells during Tumor Regression
Jacques Deguine et al.
IMMUNITY (2010)
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
Roger W. McGilvray et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Intact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1
Marine Champsaur et al.
JOURNAL OF IMMUNOLOGY (2010)
Molecular Analysis of Tumor-Promoting CD8+ T Cells in Two-Stage Cutaneous Chemical Carcinogenesis
Bernice Y. Kwong et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
Damien Sene et al.
PLOS PATHOGENS (2010)
Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD
Ester Roos-Engstrand et al.
RESPIRATORY RESEARCH (2010)
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Johannes Haybaeck et al.
CANCER CELL (2009)
Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
Kui Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
Annette Paschen et al.
CLINICAL CANCER RESEARCH (2009)
NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting
Roger W. McGilvray et al.
CLINICAL CANCER RESEARCH (2009)
Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections
Barbara Oliviero et al.
GASTROENTEROLOGY (2009)
Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
Nicole Schwinn et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
Timothy J. Nice et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
Philippe Boutet et al.
JOURNAL OF IMMUNOLOGY (2009)
Costimulation of Dendritic Epidermal γδ T Cells by a New NKG2D Ligand Expressed Specifically in the Skin
Michael I. Whang et al.
JOURNAL OF IMMUNOLOGY (2009)
Host-Derived Interleukin-1α Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells
Moshe Elkabets et al.
JOURNAL OF IMMUNOLOGY (2009)
The role of the activating receptor NKG2D in autoimmunity
Tom L. Van Belle et al.
MOLECULAR IMMUNOLOGY (2009)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Arterial blood supply of hepatocellular carcinoma and histologic grading: Radiologic-pathologic correlation
Yoshiki Asayama et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Mononuclear myeloid-derived suppressor cells express RAE-1 and activate natural killer cells
Norman Nausch et al.
BLOOD (2008)
Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
Toshiharu Sakurai et al.
CANCER CELL (2008)
Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors
Mar Vales-Gomez et al.
CANCER RESEARCH (2008)
Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis
Juan Luis Fernandez-Morera et al.
HUMAN IMMUNOLOGY (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
The expression and function of NKG2D molecule on intrahepatic CD8+T cells in chronic viral hepatitis
P. T. F. Kennedy et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis
Albrecht Buchmann et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis
Jessica Strid et al.
NATURE IMMUNOLOGY (2008)
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Noam Stern-Ginossar et al.
NATURE IMMUNOLOGY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
Jeremy B. Swann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Tiffany Horng et al.
NATURE IMMUNOLOGY (2007)
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus
Silvia Vilarinho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis
Cristina Cerboni et al.
BLOOD (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells
Chun-Jen Chen et al.
NATURE MEDICINE (2007)
RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity
Wei Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer
Stephanie Schrambach et al.
PLOS ONE (2007)
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions
Matthieu Allez et al.
GASTROENTEROLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis
Scott J. Roberts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
Vera Rebmann et al.
CLINICAL IMMUNOLOGY (2007)
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
Luca Di Tommaso et al.
HEPATOLOGY (2007)
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
Alexandre Boissonnas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells
Yongyan Chen et al.
HEPATOLOGY (2007)
Random migration precedes stable target cell interactions of tumor-infiltrating T cells
Paulus Mrass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
Guenter Eisele et al.
BRAIN (2006)
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
Claire L. Sutherland et al.
BLOOD (2006)
IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-β in NK cells via the c-Jun N-terminal kinase (JNK) pathway
Hyunkeun Song et al.
CELLULAR IMMUNOLOGY (2006)
Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity
Veronika Groh et al.
NATURE IMMUNOLOGY (2006)
Proteolytic release of soluble UL16-binding protein 2 from tumor cells
I Waldhauer et al.
CANCER RESEARCH (2006)
Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients
Helmut Rainer Salih et al.
HUMAN IMMUNOLOGY (2006)
Soluble MICA in malignant diseases
S Holdenrieder et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
IL-21 down-regulates NKG2D/DAP10 express on human NK and CD8+ T cells
SJ Burgess et al.
JOURNAL OF IMMUNOLOGY (2006)
IFN-Dependent down-regulation of the NKG2D ligand H60 on tumors
JD Bui et al.
JOURNAL OF IMMUNOLOGY (2006)
Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance
T Hayashi et al.
CANCER RESEARCH (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1:: Regulation by SOCS3
R Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
NKG2D function protects the host from tumor initiation
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
Costimulation through NKG2D enhances murine CD8+ CTL function:: Similarities and differences between NKG2D and CD28 costimulation
MA Markiewicz et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-21 enhances tumor rejection through a NKG2D-dependent mechanism
R Takaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
K Wiemann et al.
JOURNAL OF IMMUNOLOGY (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Cutting edge:: NKG2D is a costimulatory receptor for human naive CD8+ T cells
K Maasho et al.
JOURNAL OF IMMUNOLOGY (2005)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
MR Verneris et al.
BLOOD (2004)
Cutting edge:: Novel priming of tumor-speciftic immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway
JA Westwood et al.
JOURNAL OF IMMUNOLOGY (2004)
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma
L Raffaghello et al.
NEOPLASIA (2004)
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
B Meresse et al.
IMMUNITY (2004)
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease
S Hüe et al.
IMMUNITY (2004)
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer
JD Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice
MC Yu et al.
HEPATOLOGY (2004)
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
JS Lee et al.
NATURE GENETICS (2004)
NKG2D blockade prevents autoimmune diabetes in NOD mice
K Ogasawara et al.
IMMUNITY (2004)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
The distinct contributions of murine T cell receptor (TCR)γδ+ and TCRαβ+ T cells to different stages of chemically induced skin cancer
M Girardi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rhe'umatoid arthritis
V Groh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity
C Maccalli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases
S Zompi et al.
NATURE IMMUNOLOGY (2003)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Symmetry recognizing asymmetry: Analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands
BJ McFarland et al.
STRUCTURE (2003)
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
S Gilfillan et al.
NATURE IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes
G Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The role of the NKG2D immunoreceptor in immune cell activation and natural killing
AM Jamieson et al.
IMMUNITY (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection
JL Baron et al.
IMMUNITY (2002)
Crystal structures of RAE-1 beta and its complex with the activating immunoreceptor NKG2D
PW Li et al.
IMMUNITY (2002)
Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment
AI Roberts et al.
JOURNAL OF IMMUNOLOGY (2001)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions
CL Sutherland et al.
IMMUNOLOGICAL REVIEWS (2001)
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
A Cerwenka et al.
IMMUNITY (2000)
分享论文
